Jasper Therapeutics grants 7,500 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Jasper Therapeutics, Inc. reported that director Judith Anne Shizuru received an automatic grant of a stock option for 7,500 shares of Voting Common Stock on July 31, 2026, under the Non-Employee Director Compensation Policy. The option has a $0.63 exercise price, vests in full on July 31, 2027, and expires on July 31, 2036, leaving her with 7,500 options held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy F1 | 7,500 | $0.00 | $0.00 |
Footnotes (1)
- F1. Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.
Key Figures
Key Terms
Non-Employee Director Compensation Policy financial
Stock Option (Right to Buy financial
Voting Common Stock financial
vest in full financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Jasper Therapeutics (JSPR) report on July 31, 2026?
Who received the new stock option grant at Jasper Therapeutics (JSPR)?
What are the exercise price, vesting, and expiration terms of the JSPR director option grant?
Was the Jasper Therapeutics (JSPR) option grant made under a formal director compensation policy?
How many derivative securities does the JSPR director hold after this option grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.